This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Learn wealth preservation techniques for high net worth individuals designed to safeguard your wealth and ensure a lasting legacy. Take action now!
24,205 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Harvest Capital and TPG Credit have closed a $600 million recapitalization line for Metro Development Group, enabling...
Rocket Lab unveiled an approximately $8 billion plan to acquire Iridium, aiming to become a full-stack space operator...
A couple can retire at 65 in Colorado's Rockies on a $1.2 million nest egg by selecting affordable mountain towns and...
This week brought a notable pullback in AI hardware names, including CoreWeave. Read a clear, practical look at what ...
AI’s hardware backbone goes beyond chips. This deep dive explains why Vertiv and Eaton are pivotal to the AI boom, fr...
Apple just pulled back after a strong run, leaving investors wondering if now is the time to buy. This article uses h...
A hidden tracker linked to Claude drew privacy concerns in crypto apps. The move to remove it sparks a broader discus...
Meta is pursuing a bold, dual-track strategy: build massive data centers to fuel AI workloads while exploring a poten...
Homeowners may reduce monthly costs by recasting their existing loan balance, avoiding new appraisals or credit check...
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...
A new approach to retirement income uses a dividend growth roadmap that prioritizes rising payouts over static yields...